North America is expected to remain the leading regional market for digital migraine treatment devices through 2034, supported by advanced neurological care infrastructure, increasing awareness of non-pharmacological migraine therapies, and favorable reimbursement developments. The region accounted for approximately 39–42% of the digital migraine treatment device market in 2025 and is...